Cannabis Science, Inc. is conducting innovative research, developing novel cannabinoid-based therapies for the treatment of cancer and infectious diseases, such as HIV. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize phytocannabinoid-based therapies.
Cannabis Science takes a patient oriented approach to healing medicine with a number of cannabinoid based programs. Our immediate focus is to be at the cutting edge of treating many diseases and their symptoms in some of the largest markets in the world – first and foremost, Cancer. The Company’s future endeavors include Pain Management, Arthritis, and Post Traumatic Stress Disorder in our veterans.
We are dedicated to working closely with US Federal, State, and Local regulatory agencies, as well as Health Canada, to provide access in order to ensure top of the line to high quality, first class cannabinoid pharmaceuticals to those critically in need of new treatments for life and quality of life threatening conditions.
Cannabis Science is based in Colorado Springs, Colorado and lead by CEO Dr. Robert Melamede Ph.D., tenured professor and former chairman of the Biology department at the University of Colorado in Colorado Springs, CO.